The HALP(hemoglobin, albumin, lymphocyte, and platelet) score, which is calculated using hemoglobin, albumin, lymphocyte, and platelet levels, is one such index that has been studied in several cancers, including renal cell carcinoma, lung cancer, and gastric cancer (4–6). This evidence concerns the gene ALB and hereditary clear cell renal cell carcinoma.